Cargando…
Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
The “vicious cycle” established between tumor growth and osteolysis aggravates the process of breast cancer bone metastasis, leading to life-threatening skeletal-related events that severely reduce survival and quality of life. To effectively interrupt the “vicious cycle”, innovative therapeutic str...
Autores principales: | Huang, Yanjuan, Xiao, Zhanghong, Guan, Zilin, Zeng, Zishan, Shen, Yifeng, Xu, Xiaoyu, Zhao, Chunshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745129/ https://www.ncbi.nlm.nih.gov/pubmed/33354509 http://dx.doi.org/10.1016/j.apsb.2020.06.006 |
Ejemplares similares
-
Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer
por: Huang, Yanjuan, et al.
Publicado: (2021) -
Local treatment of a bone graft by soaking in zoledronic acid inhibits bone resorption and bone formation. A bone chamber study in rats
por: Belfrage, Ola, et al.
Publicado: (2012) -
Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023) -
Topical zoledronic acid decreases micromotion induced bone resorption in a sheep arthroplasty model
por: Jakobsen, Thomas, et al.
Publicado: (2017) -
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
por: Hilton, J.F., et al.
Publicado: (2017)